Express Pharma

Merck’s endeavour has been to expedite the journey of the vaccine molecule with our technologies and expertise

As we continue to track COVID variants and rising monkeypox cases, Aditya Sharma, Head – Bioprocessing, Merck Life Science India, explains to Viveka Roychowdhury how Merck’s Collaboration Labs in India and APAC helped vaccine makers ramp up in record time to meet emergency immunisation drives and continue to support the sector with investments spanning traditional and novel modalities like mAbs, ADCs, HP-APIs, viral vectors and mRNA vaccines

1 332